StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Phibro Animal Health's enterprise value was $1.97B on Nov 11, 2026, against $2.25B a year earlier. Over the last 5 years it ranged from $626.15M to $2.81B, with a median of $1.04B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.97B-4.4%
2025Dec 31, 2025$2.07B+95.4%
2024Dec 31, 2024$1.06B+49.5%
2023Dec 29, 2023$706.75M-6.1%
2022Dec 30, 2022$753.04M-27.3%
2021Dec 31, 2021$1.04B+11.6%
2020Dec 31, 2020$928.34M+2.8%
2019Dec 31, 2019$903.05M+84.1%
2018Dec 31, 2018$490.55M-5.8%
2017Dec 29, 2017$520.78M-21.7%
2016Jul 29, 2016$665.01M-42.5%
2015Dec 31, 2015$1.16B-10.0%
2014Dec 31, 2014$1.28B–

More Phibro Animal Health figures

See a number that looks wrong?